1 |
Executive Summary |
1.1 |
Main Findings |
1.2 |
Main Conclusions |
1.3 |
Bio-Detection Market Forecast 2011-2016 |
1.3.1 |
Overview |
1.3.2 |
Systems and Service & Upgrade Markets 2011-2016 |
1.3.3 |
Systems & Service Market by Modality 2011-2016 |
1.3.4 |
Systems & Service Market by Technology Generation 2011-2016 |
1.4 |
Bio-Detection Next Generation Business Opportunities |
1.5 |
Technologies Outlook |
2 |
Introduction |
2.1 |
Scope |
2.2 |
Methodology |
2.2.1 |
Research Methods |
2.2.2 |
Report Structure |
2.2.3 |
Assumptions |
2.3 |
Who is This Report For? |
3 |
Bio-Detection Market Drivers |
4 |
Bio-Detection Market Inhibitors |
5 |
Bio-Detection Industry Competitive Analysis |
6 |
Bio-Detection Industry SWOT Analysis |
7 |
Bio-detection Market Dynamics |
8 |
Defending Against Bioterrorism |
8.1 |
Definition of Bioterrorism |
8.2 |
The Threat of Bioterrorism |
8.3 |
How Real Is The Bioterrorism Threat? |
8.4 |
Bio-Defense Programs |
8.4.1 |
Strategy |
8.4.2 |
Project BioWatch |
8.4.3 |
Project BioSense |
8.4.4 |
Project BioShield |
8.5 |
Bio-Detection The Industry |
9 |
The Obama Administration Bio Terror Mitigation Strategy |
9.1 |
Biosurveillance Network |
9.2 |
Bio-Defense Funding |
9.2.1 |
Overview |
9.2.2 |
DHHS Bio-Defense Missions and Funding |
9.2.3 |
DHS Bio-Defense Missions and Funding |
9.2.4 |
DOD Bio-Defense Missions and Funding |
9.2.5 |
DOA Bio-Defense Missions and Funding |
9.2.6 |
EPA Bio-Defense Missions and Funding |
9.3 |
The Obama Administration Bio-Defense Strategy |
10 |
Bio-Detection Technologies Overview |
10.1 |
Bio-Detection Technology Challenges |
10.1.1 |
Sampling the Environment |
10.2 |
The Bio-Detection Process |
10.2.1 |
Bio-Detectors in a Multitude of Ambient Settings |
10.2.2 |
Bio-Detection Triggering |
10.2.3 |
Collection of Particles |
10.2.4 |
Bio-Particle Detectors |
10.2.5 |
Bio-Agent Identification |
11 |
Major Bio-Detection Technological Challenges |
11.1 |
Challenge 1 Detection of Small Particle Concentration |
11.2 |
Challenge 2 Eliminating Bio Background |
11.3 |
Challenge 3 Expensive Reagents |
11.4 |
Challenge 4 Expensive Equipment Maintenance |
11.5 |
Challenge 5 Adapting Equipment to Changing Environments |
11.6 |
Challenge 6 Dealing With Emerging Threats |
12 |
Bio Detection Technologies Review & Outlook 2011-2016 |
12.1 |
Bio-Detection Core Technologies Comparison |
12.2 |
Collector/Concentrator Core Technologies |
12.3 |
Cyclone Collectors |
12.4 |
Variable Particle-Size Impactor |
12.5 |
Virtual Impactors |
12.6 |
Impingers |
12.7 |
Reagentless Trigger Core Technologies |
12.7.1 |
Flow Cytometry |
12.7.2 |
Particle Sizing |
12.7.3 |
Gas Chromatography |
12.7.4 |
Trigger Technologies Drivers |
12.7.5 |
Trigger Technologies Inhibitors |
12.8 |
DNA Based Diagnostic Core Technologies |
12.8.1 |
Overview of DNA-Based Detection |
12.8.2 |
Polymerase Chain Reaction (PCR) |
12.8.3 |
DNA / RNA Microarrays |
12.8.4 |
DNA Technology Drivers |
12.8.5 |
DNA Technology Inhibitors |
12.9 |
Antibody-Antigen Diagnostic Core Technologies |
12.9.1 |
Overview of Antibody-Antigen Reaction |
12.9.2 |
Hand-Held Immuno-Chromatographic Assays (HHA) |
12.9.3 |
Magnetic Microbead-Base Assays |
12.9.4 |
Microfluidic Devices “Lab on a Chip” |
12.9.5 |
Fluorescence Imaging |
12.9.6 |
Electrochemical-Luminescence (ECL) |
12.9.7 |
Antibody/Antigen Technology Drivers |
12.9.8 |
Antibody/Antigen Technology Inhibitors |
12.1 |
Signal Analysis Algorithms |
12.10.1 |
Clustering / Classifier Algorithms |
12.10.2 |
Image Analysis Algorithms |
12.10.3 |
Decision Algorithms |
12.10.4 |
Algorithm Drivers |
12.10.5 |
Algorithm Inhibitors |
12.11 |
Rapid Microbiological Technologies |
13 |
Biological Detection Overview by Application |
13.1.1 |
Application 1 Emergency Responder Hand-Held Detectors |
13.1.2 |
Application 2 Emergency Responder Mobile Labs |
13.1.3 |
Application 3 Indoor Standoff Detectors |
13.1.4 |
Application 4 Outdoor Standoff Detectors |
14 |
U.S. Bio-Detection Systems Market Outlook 2011-2016 |
14.1 |
Methodology |
14.2 |
Bio-Detection Systems Sales 2011-2016 |
14.2.1 |
Bio-Detection Systems Revenue Sales by Generation Forecast 2011-2016 |
14.2.2 |
Bio-Detection Systems Sales by Modality 2011-2016 |
14.3 |
Bio-Detection Systems Quantity Sales 2011-2016 |
14.3.1 |
Bio-Detection Systems Quantity Sales by Generation 2011-2016 |
14.3.2 |
Bio-Detection Systems Quantity Sales by Modality 2011-2016 |
14.4 |
Outdoor Bio-Detection Systems Market 2011-2016 |
14.4.1 |
Outdoor Standoff Detection Systems Revenue Sales Outlook 2011-2016 |
14.4.2 |
Outdoor Standoff Detection Systems Quantity Sales Outlook 2011-2016 |
14.5 |
Indoor Bio-Detection Systems Market 2011-2016 |
14.5.1 |
Indoor Standoff Systems Detection Sales 2011-2016 |
14.5.2 |
Indoor Standoff Systems Unit Sales 2011-2016 |
14.6 |
First Responder Hand-Held Bio-Detection Systems Market 2011-2016 |
14.6.1 |
First Responder Hand-Held Systems Sales 2011-2016 |
14.6.2 |
First Responder Hand-Held Systems Quantity Sales 2011-2016 |
14.7 |
Mobile Bio-Detection Labs Market 2011-2016 |
14.7.1 |
First Responder Mobile Labs Sales 2011-2016 |
14.7.2 |
First Responder Mobile Labs Quantity Sales 2011-2016 |
15 |
Service & Upgrade Business 2011-2016 |
15.1 |
Bio-Detection Service & Upgrade Business by Modality 2011-2016 |
15.2 |
Bio-Detection Service Business by Technology Generation 2011-2016 |
16 |
Business Opportunities in Bio-Detection 2011-2016 |
16.1 |
Historical Perspective |
16.1.1 |
A Market Waiting for Transition |
16.1.2 |
The Current and Future HLS Bio-Defense Strategy for Detection |
16.1.3 |
Factors Affecting Biological Detectors Deployment and Technologies 2011-2016 |
16.1.4 |
Biological Detection Technology Timeline |
16.2 |
Next Generation HLS Bio-Detection Systems Business Opportunities |
16.2.1 |
Overview |
16.2.2 |
Business Opportunity 1 Emerging Threats |
16.2.3 |
Business Opportunity 2 Human Sentinel Surveillance System |
16.2.4 |
Business Opportunity 3 Animal Sentinel Surveillance System |
16.2.5 |
Business Opportunity 4 Biological IC3 Biological Threat Assessment Intelligence Command, Control, and Communication Infrastructure |
16.2.6 |
Business Opportunity 5 Reducing False Alarms Lesser False Positives and False Negatives |
16.2.7 |
Business Opportunity 6 Reducing Cost Minimizing Use of Non-Reusable Reagents |
16.3 |
Outdoor Standoff Biological Detectors |
16.3.1 |
Business Opportunity 7 Bioagent Autonomous Networked Detectors (BAND) |
16.3.2 |
Business Opportunity 8 Rapid Automated Biological Identification System (RABIS) |
16.3.3 |
Business Opportunity 9 First Responder Portable Hand-Held Detector |
16.3.4 |
Business Opportunity 10 First Responder Mobile Biological Detection Station |
16.3.5 |
Business Opportunity 11 Regional Automatic Detector Outdoor Standoff Detectors |
16.3.6 |
Business Opportunity 12 Networked Automatic Detector Indoor Standoff Detectors |
16.3.7 |
Business Opportunity 13 External Spread of Bioagent Detection |
16.3.8 |
Business Opportunity 14 Internal Spread of Bioagent |
16.4 |
Other Bio-Detection Technologies Business Opportunities |
16.4.1 |
Business Opportunity 15 “Lab on a Chip” Miniature Detection Devices |
16.4.2 |
Business Opportunity 16 Reagentless Specific Detection Assays |
16.4.3 |
Business Opportunity 17 Laser Induced Breakdown Spectroscopy (LIBS) |
16.4.4 |
Business Opportunity 18 Raman Spectroscopy-based Reagentless Detection |
16.5 |
Future Technologies and Systems |
17 |
Bio-Detection Personnel Considerations |
17.1 |
Background Personnel |
17.2 |
Personnel Training |
18 |
Vendors |
18.1 |
20/20 GeneSystems Inc. |
18.2 |
Advnt Biotechnologies |
18.3 |
Agilent Technologies |
18.4 |
Alexeter Technologies |
18.5 |
ANP Technologies, Inc. |
18.6 |
BAS – Biological Alarm Systems Ltd. (Israel) |
18.7 |
BD Biosciences Immunocytometry Systems |
18.8 |
Bertin Technologies |
18.9 |
BioDefense Corporation |
18.1 |
BioDETECT AS |
18.11 |
BioSentinel Pharmaceuticals LLC |
18.12 |
3M Microbiology (Biotrace International, Ltd.) |
18.13 |
BioTraces, Inc. |
18.14 |
BioVeris Corporation |
18.15 |
Biral |
18.16 |
Cepheid |
18.17 |
Commonwealth Biotechnologies, Inc. |
18.18 |
Dycor Technologies Ltd. |
18.19 |
Environics Oy |
18.2 |
Evogen, Inc. |
18.21 |
General Dynamics Canada |
18.22 |
GenPrime, Inc. |
18.23 |
Groton Biosystems |
18.24 |
Haztech Systems, Inc. |
18.25 |
Idaho Technology, Inc. |
18.26 |
JMAR Technologies, Inc. |
18.27 |
New Horizons Diagnostics |
18.28 |
Proengin |
18.29 |
QTL Biodetection |
18.3 |
Research International |
18.31 |
Response Biomedical |
18.32 |
Roche Applied Science |
18.33 |
Smiths Detection |
18.34 |
Tetracore, Inc. |
19 |
Prices of Bio-Detection Equipment |
20 |
Appendix A: The Threat of Bioweapons |
20.1 |
Use of Bioweapons Historical Perspective |
20.2 |
Biological Terror Bacterial Agents |
20.2.1 |
Anthrax |
20.2.2 |
Cholera |
20.2.3 |
Plague |
20.2.4 |
Tularemia |
20.3 |
Biological Terror Viral Agents |
20.3.1 |
Smallpox |
20.3.2 |
Hemorrhagic Fever Viruses |
20.3.3 |
Venezuelan Equine Encephalitis |
20.4 |
Biological Terror Rickettsiae Agents |
20.4.1 |
Q Fever |
20.4.2 |
Typhus |
20.5 |
Biological Terror Toxins |
20.5.1 |
Botulinum Toxin |
20.5.2 |
Ricin |
20.5.3 |
Saxitoxin |
20.5.4 |
Staphylococcal Enterotoxin B (SEB) |
21 |
Appendix B: Legal Issues |
21.1 |
International / European Legislation / Agreements |
21.1.1 |
The Biological and Toxin Weapons Convention (BTWC) 1972 |
21.2 |
U.S. Bioterrorism Legislation |